ArticleJournal of orthopaedic surgery and research2025
The role of the infrapatellar fat pad in osteoporotic knee osteoarthritis: bone-fat crosstalk: cross-sectional studies.
Article in Journal of orthopaedic surgery and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundsOsteoporosis (OP) and osteoarthritis (OA) of the knee are common and serious human health problems. However, the relationship between knee OP and the progression of OA, and the potential association between knee OP and adipose tissue within the knee, is not well understood. This study aims to characterize differences in IPFP morphology and lipid metabolism markers, bone metabolism profiles between patients with isolated knee OA and those with concurrent OA and OP, to explore potential mechanisms linking adipose tissue dysfunction to OA-OP comorbidity.
methodsThis study enrolled 402 participants (89 healthy volunteers, 100 knee OA patients, 108 OP patients, and 105 OA + OP patients) from September 2011 to January 2023. Synovial inflammation markers (effusion grading: 0-3; IPFP abnormalities: 0-3; synovial proliferation: 0-2) and structural knee abnormalities (Whole-Organ Magnetic Resonance Imaging Score [WORMS]: cartilage, bone marrow edema, meniscus sub-scores) were assessed via MRI. Pathological analysis of IPFP tissue (fibrosis: 0-3; vascularization: 0-2) was performed by two blinded pathologists in OA patients undergoing arthroplasty. Clinical outcomes (WOMAC, Oxford Knee Score, Anterior Knee Pain Score) were evaluated preoperatively and at 1-year follow-up. Risk factors (triglycerides, hip BMD, IPFP abnormalities) were analyzed using LASSO regression with 10-fold cross-validation.
resultsThe OA + OP group exhibited higher grades of synovial effusion (mean ± SD: 2.1 ± 0.7 vs. 1.3 ± 0.5, p < 0.01), IPFP abnormalities (2.4 ± 0.6 vs. 1.8 ± 0.4), and synovial proliferation scores (1.9 ± 0.5 vs. 1.2 ± 0.3) compared to the OA group. Total WORMS scores were significantly elevated in OA + OP (32.5 ± 8.2 vs. 24.1 ± 6.5, p < 0.001), driven by higher cartilage degradation, increase of bone marrow edema, and meniscus damage sub-scores. Pathological analysis confirmed increased fibrosis (2.7 ± 0.4 vs. 1.9 ± 0.3) and vascularization (1.8 ± 0.5 vs. 1.1 ± 0.2) in OA + OP. At 1-year follow-up, OA + OP patients had worse WOMAC (45.2 ± 10.1 vs. 33.5 ± 8.7) and OKS (22.1 ± 5.3 vs. 28.4 ± 4.9). LASSO regression identified TG, total hip BMD, and IPFP abnormalities as key risk factors.
conclusionOur results identify a pathophysiological triad of (1) IPFP fibrosis/hypervascularization, (2) systemic hypertriglyceridemia, and (3) low BMD that collectively accelerates structural degeneration and symptom progression in knee OA. While genetic and biomechanical factors initiate OA pathogenesis, these acquired metabolic-inflammatory mechanisms represent tractable therapeutic targets for modifying disease evolution in established OA, particularly with OP comorbidity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.